Results 171 to 180 of about 1,318,648 (300)

Implementation and outcomes of complementary therapies in hospice care: an integrative review. [PDF]

Palliat Care Soc Pract, 2021
Dingley C, Ruckdeschel A, Kotula K, Lekhak N.   +3 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Complementary Therapies of Diabetic Peripheral Neuropathy and Intermittent Claudication. [PDF]

Healthcare (Basel)
Ng SY.
europepmc   +1 more source

Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer. [PDF]

Biomedicines, 2021
Garrido MP, Fredes AN, Lobos-González L, Valenzuela-Valderrama M, Vera DB, Romero C.   +5 more
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Scale for Assessing Understanding of Benefits and Risks of Using Complementary Therapies in Diabetes Management: Psychometric Evaluation. [PDF]

J Nurs Res
Chang HY, Huang YY, Lo CL.
europepmc   +1 more source

Discretion and local health policy implementation: street-level bureaucrats and integrative and complementary therapies in Santos' local health units. [PDF]

Prim Health Care Res Dev, 2022
Macena A, Oliveira VE.
europepmc   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

Molecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens, Anouk Mentink, Tom Niessink, Frank Coumans, Leonie Mekenkamp, Ruchi Bansal, Jeroen Hiltermann   +6 more
wiley   +1 more source

Complementary therapies in early breast cancer: Oncologists' evidence-based decisions in a Southeast European vignette survey. [PDF]

Biomol Biomed
Buhovac T, Bajić Ž, Nalbani M, Popović L, Risteski M, Milašević N, Dimitrov G, Pašić A, Karaga M, Vrdoljak E.   +9 more
europepmc   +1 more source

Effectiveness of Complementary Therapies in Cancer Patients: A Systematic Review. [PDF]

Int J Environ Res Public Health, 2021
Guerra-Martín MD, Tejedor-Bueno MS, Correa-Casado M.   +2 more
europepmc   +1 more source